Halbert Hargrove Global Advisors LLC lowered its holdings in Bristol-Myers Squibb ( NYSE:BMY – Get Rating ) by 8.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,615 shares of the biopharmaceutical company's stock after selling 339 shares during the period. Halbert Hargrove Global Advisors LLC's holdings in Bristol-Myers Squibb were worth $260,000 as of its most recent SEC filing. Other hedge funds have also made changes to their positions in the company.

https://www.dailypolitical.com/2023/04/03/halbert-hargrove-global-advisors-llc-lowers-stake-in-bristol-myers-squibb-nysebmy.html

#dailypolitical